GlassScriptPhysician profile
Joseph M Lacava
NPI 1104842814
$1,593.73
in general payments reported to CMS, 2019-2025
15 companies · $51.92 in 2025
The $51.92 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $60.85 · 2021: $89.18 · 2022: $972 · 2023: $164 · 2024: $114 · 2025: $51.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $866.46 | 2022 | |
| Horizon Therapeutics Plc | $182.59 | 2020-2023 | Krystexxa |
| Osiris Therapeutics INC. | $123.60 | 2019 | |
| Paratek Pharmaceuticals, INC. | $98.06 | 2022-2024 | Nuzyra |
| Nevro Corp. | $58.75 | 2022-2024 | Senza |
| Heron Therapeutics, INC. | $38.11 | 2021-2024 | Zynrelef |
| Trimed, INC. | $36.55 | 2022 | |
| Treace Medical Concepts, INC. | $34.06 | 2023 | |
| Amgen INC. | $31.28 | 2025 | Krystexxa |
| Kerecis Limited | $28.39 | 2020 | |
| Bioventus LLC | $23.18 | 2024 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $20.64 | 2025 | Collagenase Santyl |
| Boston Scientific Corporation | $18.90 | 2024 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $17.97 | 2019 | |
| Convatec INC. | $15.19 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lacava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.